Search - tctmd.com

Displaying 21 - 40 of 452

Sort: Relevancy | Date

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2025

Caitlin E. Cox

May 30, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Todd Neale

April 08, 2025

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

L.A. McKeown

March 30, 2025

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Presenter: John Connolly

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

October 27, 2024

Advertisement

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

TCTMD’s Top 10 Most Popular Stories for May 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

April 2025 Dispatch for the CV Team

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

What’s Going to Be Hot at ACC 2025?

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content